Hybrid AI-assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears

Technical advancements significantly improve earlier diagnosis of cervical cancer, but accurate diagnosis is still difficult due to various factors. We develop an artificial intelligence assistive diagnostic solution, AIATBS, to improve cervical liquid-based thin-layer cell smear diagnosis according...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 12; no. 1; p. 3541
Main Authors Zhu, Xiaohui, Li, Xiaoming, Ong, Kokhaur, Zhang, Wenli, Li, Wencai, Li, Longjie, Young, David, Su, Yongjian, Shang, Bin, Peng, Linggan, Xiong, Wei, Liu, Yunke, Liao, Wenting, Xu, Jingjing, Wang, Feifei, Liao, Qing, Li, Shengnan, Liao, Minmin, Li, Yu, Rao, Linshang, Lin, Jinquan, Shi, Jianyuan, You, Zejun, Zhong, Wenlong, Liang, Xinrong, Han, Hao, Zhang, Yan, Tang, Na, Hu, Aixia, Gao, Hongyi, Cheng, Zhiqiang, Liang, Li, Yu, Weimiao, Ding, Yanqing
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 10.06.2021
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Technical advancements significantly improve earlier diagnosis of cervical cancer, but accurate diagnosis is still difficult due to various factors. We develop an artificial intelligence assistive diagnostic solution, AIATBS, to improve cervical liquid-based thin-layer cell smear diagnosis according to clinical TBS criteria. We train AIATBS with >81,000 retrospective samples. It integrates YOLOv3 for target detection, Xception and Patch-based models to boost target classification, and U-net for nucleus segmentation. We integrate XGBoost and a logical decision tree with these models to optimize the parameters given by the learning process, and we develop a complete cervical liquid-based cytology smear TBS diagnostic system which also includes a quality control solution. We validate the optimized system with >34,000 multicenter prospective samples and achieve better sensitivity compared to senior cytologists, yet retain high specificity while achieving a speed of <180s/slide. Our system is adaptive to sample preparation using different standards, staining protocols and scanners. Technical advancements have significantly improved early diagnosis of cervical cancer, but accurate diagnosis is still difficult due to various practical factors. Here, the authors develop an artificial intelligence assistive diagnostic solution to improve cervical liquid-based thin-layer cell smear diagnosis according to clinical TBS criteria in a large multicenter study.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-021-23913-3